Broad testing, precise answers
With advanced genomic technologies, our unmatched internal database, and extensive clinical expertise, GeneDx’s industry-leading tests deliver clinically actionable results, faster.
Learn moreHappy Thanksgiving! Please be advised that in-transit patient samples will be held by the carrier on Nov. 28 and received by our lab on Nov 29. Kit orders placed Nov. 28-Dec. 1 will be sent on Dec 2. Our genetic counseling services, client services, and billing services will be unavailable Nov. 28-29. Leave us a message at 888-729-1206 or support@genedx.com and we will respond when we return on Dec. 2.
This and every month, you can put patients first by putting exome first.
Do conventional medical protocols send critically ill babies on an unnecessary diagnostic odyssey? A new study says yes.
First GUARDIAN study results show the power of genome sequencing in conjunction with newborn screening.
Helping more patients with epilepsy find an answer through exome sequencing.
We see a future where any genetic disorder is diagnosed quickly to prevent disease progression and ensure long and healthy lives for all.
The key? Exome and genome sequencing.
Recommended by guidelines as a first-line test. More likely to deliver a diagnosis.
The time for exome and genome is now.
Not a healthcare provider?
Learn more about testing here.
Exome sequencing
delivers 2x the diagnostic yield of chromosomal microarray (CMA) and multigene panels.1,2
Genome sequencing
is the most comprehensive genetic test available and includes mitochondrial genome sequencing.
Rapid genome sequencing
can help identify the 1 in 4 infants in the intensive care unit that likely have a genetic disorder.3
With advanced genomic technologies, our unmatched internal database, and extensive clinical expertise, GeneDx’s industry-leading tests deliver clinically actionable results, faster.
Learn moreThere’s a reason we’re the go-to lab when providers need diagnoses for children with both rare diseases and common conditions. It includes comprehensive, actionable results, unparalleled support, and a genuine dedication to putting patients first.
Ready to talk in more detail? Schedule a call today.
References: 1. Savatt JM, Myers SM. Front Pediatr. 2021 Feb 19;9:526779. doi: 10.3389/fped.2021.52679. 2. Srivastava S, Love-Nichols JA, Dies KA, et al. Genet Med. 2019 Nov;21(11):2413–2421; https://doi.org/10.1038/s41436-019-0554-6. 3. Kingsmore SF, Cakici JA, Clark MM, et al. Am J Hum Genet. 2019 Oct 3;105(4):719-733. doi: 10.1016/j.ajhg.2019.08.009.